Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Trinity Biotech

Trinity Biotech develops, manufactures and markets diagnostic test kits for the clinical laboratory and point-of-care... read more Featured Products: More products

Download Mobile App




Point-of-Care Troponin Product Meets Guidelines for Heart Attack Detection

By LabMedica International staff writers
Posted on 19 Feb 2014
A point-of-care troponin product is capable of meeting all of the guidelines stipulated by the world's leading cardiac organizations for detection.

Trinity Biotech (Wicklow, Ireland) has announced European approval of a guideline compliant, point-of-care, high sensitivity Troponin I product. More...
That is, the troponin I product has received the CE marking for its Meritas, high sensitivity Troponin I (hsTnI) product. Troponin is the leading marker used in the detection of heart attacks or myocardial infarctions (MI).

The worldwide segment for Cardiac Troponin testing is estimated to be USD 1.2 billion, growing at a rate of 12% per annum. Of this market, approximately USD 350 million represents point-of-care testing carried out in the Emergency Room (ER) with the remainder being laboratory based testing.

This test delivers sensitivity and precision at the point-of-care, which allows doctors to evaluate whether or not patients are having a heart attack within a short time of admission.

The future plans of Trinity Biotech will include an immediate launch of its Troponin product for sale in Europe and as well as commencement of US trials with the aim of receiving the US Food and Drug Administration (Silver Spring, MD, USA) approval.

Related Links:

Trinity Biotech
US Food and Drug Administration



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image

Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms

Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read more

Industry

view channel
Im

Eurobio Scientific Completes Acquisition of CareDx Lab Products Division

Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.